Mobile

Multicenter randomized open-label three-arms controlled 12 months clinical proof of concept study to evaluate efficacy and safety of Ranibizumab alone or in combination with laser treatment vs. laser ...

Update Il y a 4 ans
Reference: EUCTR2011-005542-35

Multicenter randomized open-label three-arms controlled 12 months clinical proof of concept study to evaluate efficacy and safety of Ranibizumab alone or in combination with laser treatment vs. laser treatment alone in Proliferative Diabetic Retinopathy

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

Change of area of neovascularizations as measured by Fluorescein Angiography at month 12 (difference to baseline value).

Inclusion criteria

  • Proliferative Diabetic Retinopathy

Links